Two Sigma Advisers
LUNG icon

Two Sigma Advisers’s Pulmonx LUNG Stock Holding History

Two Sigma Advisers’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,100
Closed -$47.1K – 2504
2025
Q3 		$47.1K Sell
29,100
-32,600
-53% -$68.2K ﹤0.01% 2273
2025
Q2 		$160K Sell
61,700
-73,800
-54% -$291K ﹤0.01% 2156
2025
Q1 		$912K Buy
135,500
+45,500
+51% +$322K ﹤0.01% 1512
2024
Q4 		$611K Sell
90,000
-4,900
-5% -$32.3K ﹤0.01% 1702
2024
Q3 		$787K Sell
94,900
-37,100
-28% -$268K ﹤0.01% 1519
2024
Q2 		$837K Sell
132,000
-25,500
-16% -$196K ﹤0.01% 1642
2024
Q1 		$1.46M Sell
157,500
-43,500
-22% -$510K ﹤0.01% 1386
2023
Q4 		$2.56M Sell
201,000
-25,600
-11% -$267K 0.01% 1147
2023
Q3 		$2.34M Sell
226,600
-40,200
-15% -$466K 0.01% 1113
2023
Q2 		$3.5M Sell
266,800
-4,500
-2% -$55K 0.01% 925
2023
Q1 		$3.03M Buy
271,300
+201,800
+290% +$1.99M 0.01% 1040
2022
Q4 		$586K Buy
+69,500
New +$661K ﹤0.01% 1818
2021
Q4 		– Sell
-6,400
Closed -$230K – 2729
2021
Q3 		$230K Buy
+6,400
New +$252K ﹤0.01% 2202

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers's LUNG Position: Q4 2025 in Review

Two Sigma Advisers sold out of Pulmonx (LUNG) in Q4 2025, closing a stake of 29,100 shares — an estimated $47.1K sold.

Two Sigma Advisers first reported a position in LUNG in Q3 2021 and held it in 13 quarters. The position peaked at $3.5M in Q2 2023. 112 funds tracked by Wall St. Rank hold LUNG as of Q4 2025.

  • Two Sigma Advisers reported no remaining Pulmonx position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 29,100 Pulmonx shares in Q4 2025, an estimated $47.1K.
  • Two Sigma Advisers first reported a position in Pulmonx in Q3 2021 and held it in 13 quarters.
  • Two Sigma Advisers's Pulmonx position peaked at $3.5M in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Pulmonx as of Q4 2025.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.